Aton Pharma

About:

Aton Pharma is a specialty pharmaceutical company focusing on ophthalmic diseases, orphan conditions, and acute care hospital products.

Website: http://www.atonrx.com

Top Investors: Wellcome Trust, Perseus-Soros Biopharmaceutical Fund

Description:

Aton Pharma, Inc. operates as a specialty pharmaceutical company. It focuses on ophthalmic diseases, orphan conditions, and acute care hospital products. The company offers products for metabolic, neurological, and cardiovascular diseases, as well as provides products for under-treated diseases, including dry eye. Its products include timolol maleate ophthalmic gel forming solution for the treatment of elevated intraocular pressure in patients with ocular hypertension or open-angle glaucoma. The company serves patients, caregivers, and healthcare professionals in the United States, the Asia Pacific region, Australia, and internationally. Aton Pharma, Inc. was formerly known as Avatar. The company was founded in 2001 and is based in Lawrenceville, New Jersey. Aton Pharma, Inc. is a former subsidiary of Merck & Co., Inc.

Total Funding Amount:

$13.7M

Headquarters Location:

Lawrenceville, New Jersey, United States

Founded Date:

2001-01-01

Founders:

Michael G. Wells, Paul Marks

Number of Employees:

11-50

Last Funding Date:

2003-01-10

IPO Status:

Private

Industries:

© 2025 bioDAO.ai